Interval and clinical cohort studies: Epidemiological issues

AIDS Research and Human Retroviruses

Volumn 23, Issue 6, 2007, Pages 769-776

  Lau, Bryan ^a,b   Gange, Stephen J ^b   Moore, Richard D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; ELECTRONIC MEDICAL RECORD; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFORMATION TECHNOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

BIAS (EPIDEMIOLOGY); COHORT STUDIES; EPIDEMIOLOGIC RESEARCH DESIGN; HIV INFECTIONS; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PATIENT SELECTION; RETROSPECTIVE STUDIES;

EID: 34447268935     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0171     Document Type: Article

References (46)

1. Last JM, Ed.: A Dictionary of Epidemiology, 3rd ed. Oxford University Press, New York, NY, 1995.
2. Liddell FD: The development of cohort studies in epidemiology: A review. J Clin Epidemiol 1988;41:1217-1237.
3. Samet JM and Munoz A: Evolution of the cohort study. Epidemiol Rev 1998;20:1-14.
4. Szklo M and Nieto FJ: Epidemiology Beyond the Basics. Jones and Bartlett Publishers, Sudbury, MA, 2004.
5. Tager IB: Outcomes in cohort studies. Epidemiol Rev 1998;20:15-28.
6. Szklo M: Population-based cohort studies. Epidemiol Rev 1998;20:81-90.
7. Dawber TR: The Framinglutin Study: The epidemiology of Atherosclerotic Disease. Harvard University Press, Cambridge, MA, 1980.
8. Schull WJ: Effects of Atomic Radiation: A Half-Century of Studies from Hiroshima and Nagasaki. Wiley-Liss, New York, 1995.
9. Doll R and Hill AB: The mortality of doctors in relation to their smoking habits: A preliminary report. Br Med J 1954;1:1451-1455.
10. Vlahov D, Anthony JC, Munoz A, et al.: The ALIVE study: A longitudinal study of HIV infection in intravenous drug users: Description of methods. J Drug Issues 1991;21:759-776.
11. de Wolf F, Lange JM, Houweling JT, et al.: Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis 1988;158:615-622.
12. Rezza G, Lazzarin A, Angarano G, et al.: The natural history of HIV infection in intravenous drug users: Risk of disease progression in a cohort of seroconverters. AIDS 1989;3:87-90.
13. Kaslow RA, Ostrow DG, Detels R, et al.: The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants. Am J Epidemiology 1987;126:310-318.
14. Barkan SE, Melnick SL, Preston-Martin S, et al.: The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998;9:117-125.
15. Moore RD: Understanding the clinical and economic outcomes of HIV therapy: The Johns Hopkins HIV clinical practice cohort. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17(Suppl. 1):S38-41.
16. Sudre P, Rickenbach M, Taffé P, et al.: Clinical epidemiology and research on HIV infection in Switzerland: The Swiss HIV Cohort Study 1988-2000. Schweiz Med Wochenschr 2000;130:1493-1500.
17. Strom B, Ed.: Pharmacoepidemiology, 3rd ed. John Wiley & Sons, West Sussex, UK, 2002.
18. Klein D, Hurley LB, Quesenberry CP Jr, et al.: Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 2002;30:471-477.
19. Hunt JR and White E: Retaining and tracking cohort study members. Epidemiol Rev 1998;20:57-70.
20. Criqui MM: Response bias and risk ratios in epidemiologic studies. Am J Epidemiology 1979;109:394-399.
21. Decouflé P, Holmgreen P, Calle EE, et al.: Nonresponse and intensity of follow-up in an epidemiologic study of Vietnam-era veterans. Am J Epidemiol 1991;133:83-95.
22. Psaty BM, Cheadle A, Koepsell TD, et al.: Race- and ethnicity-specific characteristics of participants lost to follow-up in a telephone cohort. Am J Epidemiol 1994;140:161-171.
23. Sackett DL: Bias in analytic research. J Chronic Dis 1979;32:51-63.
24. Criqui MH, Barrett-Connor E, Austin M: Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol 1978;108:367-372.
25. Benfante R, Reed D, MacLean C, et al.: Response bias in the Honolulu Heart Program. Am J Epidemiol 1989;130:1088-1100.
26. Macera CA, Jackson KL, Davis DR, et al.: Patterns of non-response to a mail survey. J Clin Epidemiol 1990;43:1427-1430.
27. Greenland S: Response and follow-up bias in cohort studies. Am J Epidemiol 1977;106:184-187.
28. Osborne CE and Thompson HC: Criteria for evaluation of ambulatory child health care by chart audit: Development and testing of a methodology. Final report of the Joint Committee on Quality Assurance of Ambulatory Health Care for Children and Youth. Pediatrics 1975;56(4pt. 2 Suppl.):625-692.
29. Katz JN, Chang LC, Sangha O, et al.: Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996;34:73-84.
30. Luck J, Peabody JW, Dresselhaus TR, et al.: How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. Am J Med 2000;108:642-649.
31. Crane HM, Kadane JB, Crane PK, and Kitahata MM: Diabetes case identification methods applied to electronic medical record systems: Their use in HIV-infected patients. Curr HIV Res 2006;4:97-106.
32. Bodreau DM: A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol 2004;159:308-317.
33. Werler MM, Pober BR, Nelson K, et al.: Reporting accuracy among mothers of malformed and nonmalformed infants. Am J Epidemiol 1989;129:415-421.
34. Hessol NA, Schwarcz S, Ameli N, et al.: Accuracy of self-reports of acquired immunodeficiency syndrome and acquired immunodeficiency syndrome-related conditions in women. Am J Epidemiol 2001;153:1128-1133.
35. Griffin JT, Fraser C, Gras L, et al.: The effect on treatment comparisons of different measurement frequencies in human immunodeficiency virus observational databases. Am J Epidemiol 2006;163:676-683.
36. McGee MK: Commission Ready to Work on National Health-Records System. Information Week. January 2005. Available from http://www.informationweek.com/ story/showArticle.jhtml?articleID=57700565. Accessed 7 June 2005.
37. Office for Human Research Protection: Available from http://www.hhs.gov/ ohrp. Accessed 7 June 2005.
38. Tunis SR: A clinical research strategy to support shared decision making. Health Affairs 2005;24:180-184.
39. Naylor CD, Guyatt GH: Users' guides to medical literature, X: How to use an article reporting variation in the outcomes of health services. JAMA 1996;275:554-558.
40. Holland PW: Statistics and causal inference. J Am Stat Assoc 1986;81:945-960.
41. Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003;290:1624-1632.
42. Little RJ and Rubin DB: Causal effects in clinical and epidemiological studies via potential outcomes: Concepts and analytical approaches. Annu Rev Public Health 2000;21:121-145.
43. Barron Y, Cole SR, Greenblatt RM, et al.: Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy. AIDS 2004;18:1579-1584.
44. Mocroft A, Ledergerber B, Katlama C, et al.: Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet 2003;362:22-29.
45. Friis-Moller N, Sabin CA, Weber R, et al.: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993-2003.
46. National Institutes of Health: International Epidemiologic Databases to Evaluate AIDS (IEDEA) RFA-AI-05-014. Available from http://grants1.nih.gov/ grants/guide/rfa-files/RFA-AI-05-014.html. Accessed 7 June 2005.